Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Differ ; 7(8): 685-96, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10918442

ABSTRACT

A number of oncogenes alter the regulation of the cell cycle and cell death, contributing to the altered growth of tumours. Expression of the v-Src oncoprotein in Rat-1 fibroblasts prevented cell cycle exit in response to growth factor withdrawal. Here we investigated whether survival of v-Src transformed cells in low serum is dependent on v-Src activity. We used a temperature sensitive v-Src to study the effect inactivating v-Src on transformed cells growing under low serum conditions. We found when we switched off v-Src the cells died by apoptosis characterised by activation of caspases and the stress-activated kinases, JNK (Jun N-terminal kinase) and p38 MAP (mitogen activated protein) kinase. We were able to prevent cell death by addition of serum or overexpression of Bcl-2. Thus v-Src transformed Rat-1 cells can be protected from apoptosis by serum, v-Src, or Bcl-2. We investigated how v-Src protects from apoptosis under these conditions. Amongst other effects, v-Src activates two kinases which have been shown to protect cells from apoptosis, phosphatidylinositol 3-kinase (PI3-K) and extracellular signal-regulated kinase (ERK1/2). We found that switching off v-Src led to a decrease in the activity of both PI3-K and ERK1/2, however, we found that adding a specific inhibitor of PI3-K (LY294002) to v-Src transformed Rat-1 cells grown in low serum induced apoptosis while a specific ERK kinase (MEK1) inhibitor (PD98059) had no effect. This suggests that v-Src protects from apoptosis under low serum conditions by activating PI3-K.


Subject(s)
Apoptosis , Oncogene Protein pp60(v-src)/metabolism , Animals , Caspase Inhibitors , Caspases/physiology , Cell Line , Cell Line, Transformed , Cell Survival , Culture Media , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/physiology , Oncogene Protein pp60(v-src)/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Serum Albumin, Bovine , p38 Mitogen-Activated Protein Kinases
2.
Oncogene ; 18(41): 5646-53, 1999 Oct 07.
Article in English | MEDLINE | ID: mdl-10523844

ABSTRACT

Focal adhesion kinase (pp125FAK) is present at sites of cell/extracellular matrix adhesion and has been implicated in the control of cell behaviour. In particular, as a key component of integrin-stimulated signal transduction pathways, pp125FAK is involved in cellular processes such as spreading, motility, growth and survival. In addition, a number of reports have indicated that pp125FAK may be up-regulated in human tumour cells of diverse origin, and consequently, a role has been proposed for pp125FAK in the development of invasive cancers. However, to date the mechanisms that lead to elevated pp125FAK expression in tumour cells have not been determined. Here we used in situ hybridization to confirm chromosome 8q as the genomic location of the human fak gene and report that elevation of pp125FAK protein in cell lines derived from invasive squamous cell carcinomas is accompanied by gains in copy number of the fak gene in all cases examined. In addition, we observed increased fak copy number in frozen sections of squamous cell carcinomas. Furthermore, increased dosage of the fak gene was also observed in many cell lines derived from human tumours of lung, breast and colon, including two cell lines Calu3 and HT29, in which fak was amplified. In addition, in an in vitro model for human colon cancer progression there was a copy number gain of the fak gene during conversion from adenoma to carcinoma, which was associated with increased pp125FAK protein expression. Thus, we show for the first time that many cell lines derived from invasive epithelial tumours have increased dosage of the fak gene, which may contribute to the elevated protein expression commonly observed. Although other genes near the fak locus are co-amplified or increased in copy number, including the proto-oncogene c-myc, the biological properties of pp125FAK in controlling the growth, survival and invasiveness of tumour cells, suggest that it may contribute to the selection pressure for maintaining increased dosage of the region of chromosome 8q that encodes these genes.


Subject(s)
Carcinoma, Squamous Cell/genetics , Cell Adhesion Molecules/genetics , Gene Expression Regulation, Neoplastic , Head and Neck Neoplasms/genetics , Neoplasm Proteins/genetics , Protein-Tyrosine Kinases/genetics , Adenoma/enzymology , Adenoma/genetics , Adenoma/pathology , Breast Neoplasms/enzymology , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Carcinoma/enzymology , Carcinoma/genetics , Carcinoma/pathology , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/pathology , Cell Adhesion Molecules/biosynthesis , Chromosomes, Human, Pair 8/genetics , Colonic Neoplasms/enzymology , Colonic Neoplasms/genetics , Colonic Neoplasms/pathology , Enzyme Induction , Female , Focal Adhesion Kinase 1 , Focal Adhesion Protein-Tyrosine Kinases , Gene Amplification , Gene Dosage , Genes, myc , Head and Neck Neoplasms/enzymology , Head and Neck Neoplasms/pathology , Humans , In Situ Hybridization, Fluorescence , Lung Neoplasms/enzymology , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Neoplasm Invasiveness/genetics , Neoplasm Proteins/biosynthesis , Protein-Tyrosine Kinases/biosynthesis , Proto-Oncogene Mas , Selection, Genetic , Signal Transduction/genetics , Tumor Cells, Cultured/enzymology
3.
Genome Res ; 6(4): 235-48, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8723717

ABSTRACT

We have used Y-specific cosmid clones in a random fingerprinting approach to build contigs on the human Y chromosome. Clones derived from two libraries have been analyzed. The construction of one library is described here, the second was the Y chromosome-specific library LLOYNCO3 "M" (Lawrence Livermore National Laboratory). To date, we have fingerprinted 4430 cosmids: 377 contigs have been constructed containing from 2 to 39 clones. Along with the singletons, we estimate that we have covered 72.5% of the euchomatic portion of the Y chromosome with fingerprinted clones. Sequence tagged sites are being used to anchor cosmids and contigs onto the YAC framework.


Subject(s)
Chromosome Mapping/methods , Cosmids , DNA Fingerprinting , Y Chromosome , Base Sequence , Cloning, Molecular , DNA Primers , Humans , Molecular Sequence Data
SELECTION OF CITATIONS
SEARCH DETAIL
...